Epidemiological, Neurobiological, and Genetic Clues to the Mechanisms Linking Cannabis Use to Risk for Nonaffective Psychosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epidemiological, Neurobiological, and Genetic Clues to the Mechanisms Linking Cannabis Use to Risk for Nonaffective Psychosis
Authors
Keywords
-
Journal
Annual Review of Clinical Psychology
Volume 10, Issue 1, Pages 767-791
Publisher
Annual Reviews
Online
2014-01-29
DOI
10.1146/annurev-clinpsy-032813-153631
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes
- (2013) S. Alemany et al. ACTA PSYCHIATRICA SCANDINAVICA
- Modulation of brain structure by catechol-O-methyltransferaseVal158Metpolymorphism in chronic cannabis users
- (2013) Albert Batalla et al. ADDICTION BIOLOGY
- Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
- (2013) Alice Egerton et al. BIOLOGICAL PSYCHIATRY
- Chronic effects of cannabis on sensory gating
- (2013) Samantha J. Broyd et al. INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY
- Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
- (2013) LANCET
- COMT val158met and 5-HTTLPR Genetic Polymorphisms Moderate Executive Control in Cannabis Users
- (2013) Antonio Verdejo-García et al. NEUROPSYCHOPHARMACOLOGY
- Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: 18F-Fallypride Positron Emission Tomography Study
- (2013) Rebecca Kuepper et al. PLoS One
- The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val158Met polymorphism
- (2013) Christiaan H. Vinkers et al. SCHIZOPHRENIA RESEARCH
- Predictors of a clinical high risk status among individuals with a family history of psychosis
- (2013) Jacqueline Stowkowy et al. SCHIZOPHRENIA RESEARCH
- Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing
- (2012) Sagnik Bhattacharyya ARCHIVES OF GENERAL PSYCHIATRY
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Dopamine Release in Chronic Cannabis Users: A [11C]Raclopride Positron Emission Tomography Study
- (2012) Nina B.L. Urban et al. BIOLOGICAL PSYCHIATRY
- Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users
- (2012) Marta Di Forti et al. BIOLOGICAL PSYCHIATRY
- The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia
- (2012) J. C. Arnold et al. CURRENT PHARMACEUTICAL DESIGN
- Genetic Variation Underlying Psychosis-inducing Effects of Cannabis: Critical Review and Future Directions
- (2012) Jeroen Decoster et al. CURRENT PHARMACEUTICAL DESIGN
- A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation
- (2012) Antonio Waldo Zuardi et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Endocannabinoid Signaling and Synaptic Function
- (2012) Pablo E. Castillo et al. NEURON
- Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO
- (2012) Romina Mizrahi et al. NEUROPSYCHOPHARMACOLOGY
- Chronic Adolescent Exposure to Delta-9-Tetrahydrocannabinol in COMT Mutant Mice: Impact on Indices of Dopaminergic, Endocannabinoid and GABAergic Pathways
- (2012) Áine T Behan et al. NEUROPSYCHOPHARMACOLOGY
- Persistent cannabis users show neuropsychological decline from childhood to midlife
- (2012) M. H. Meier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studies
- (2012) Marie-Anne El Khoury et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Alteration to hippocampal shape in cannabis users with and without schizophrenia
- (2012) Nadia Solowij et al. SCHIZOPHRENIA RESEARCH
- Childhood sexual trauma, cannabis use and psychosis: statistically controlling for pre-trauma psychosis and psychopathology
- (2012) Jamie Murphy et al. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
- Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism
- (2011) G. Estrada et al. ACTA PSYCHIATRICA SCANDINAVICA
- A Critical Review of the First 10 Years of Candidate Gene-by-Environment Interaction Research in Psychiatry
- (2011) Laramie E. Duncan et al. AMERICAN JOURNAL OF PSYCHIATRY
- Endocannabinoid tone versus constitutive activity of cannabinoid receptors
- (2011) Allyn C. Howlett et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabis, COMT and psychotic experiences
- (2011) Stanley Zammit et al. BRITISH JOURNAL OF PSYCHIATRY
- Synthetic delta-9-tetrahydrocannabinol elicits schizophrenia-like negative symptoms which are distinct from sedation
- (2011) P. D. Morrison et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels
- (2011) Matthias Klugmann et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes
- (2011) Colm M. P. O'Tuathaigh et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids
- (2011) Sharon Anavi-Goffer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability
- (2011) Paul RA Stokes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder
- (2011) Ruud van Winkel et al. NEUROPSYCHOPHARMACOLOGY
- Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study
- (2011) Toby T Winton-Brown et al. NEUROPSYCHOPHARMACOLOGY
- Endocannabinoids and Retrograde Modulation of Synaptic Transmission
- (2011) Takako Ohno-Shosaku et al. NEUROSCIENTIST
- Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk
- (2011) M. Konings et al. PSYCHOLOGICAL MEDICINE
- Cannabis use and psychosis: re-visiting the role of childhood trauma
- (2011) J. E. Houston et al. PSYCHOLOGICAL MEDICINE
- Cerebellar white-matter changes in cannabis users with and without schizophrenia
- (2011) N. Solowij et al. PSYCHOLOGICAL MEDICINE
- Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
- (2011) C. J. A. Morgan et al. PSYCHOLOGICAL MEDICINE
- Do cannabis and urbanicity co-participate in causing psychosis? Evidence from a 10-year follow-up cohort study
- (2011) R. Kuepper et al. PSYCHOLOGICAL MEDICINE
- The effects of cannabis use on neurocognition in schizophrenia: A meta-analysis
- (2011) Rachel A. Rabin et al. SCHIZOPHRENIA RESEARCH
- Non-replication of interaction between cannabis use and trauma in predicting psychosis
- (2011) Rebecca Kuepper et al. SCHIZOPHRENIA RESEARCH
- Interaction between COMT haplotypes and cannabis in schizophrenia: A case-only study in two samples from Spain
- (2011) Javier Costas et al. SCHIZOPHRENIA RESEARCH
- Cannabis with high cannabidiol content is associated with fewer psychotic experiences
- (2011) Christian D. Schubart et al. SCHIZOPHRENIA RESEARCH
- Variabilidad en el gen COMT y modificación del riesgo de esquizofrenia conferido por consumo de cannabis
- (2011) Blanca Gutiérrez et al. Revista de Psiquiatria y Salud Mental
- Association between cannabis and psychiatric hospitalization
- (2010) C. D. Schubart et al. ACTA PSYCHIATRICA SCANDINAVICA
- Association Between Cannabis Use and Psychosis-Related Outcomes Using Sibling Pair Analysis in a Cohort of Young Adults
- (2010) John McGrath et al. ARCHIVES OF GENERAL PSYCHIATRY
- Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of CannabisSibling Analysis and Proband Follow-upGenetic Variation Underlying Cannabis Effects
- (2010) Ruud van Winkel ARCHIVES OF GENERAL PSYCHIATRY
- Evidence That Familial Liability for Psychosis Is Expressed as Differential Sensitivity to Cannabis
- (2010) ARCHIVES OF GENERAL PSYCHIATRY
- Reduced Cortical Thickness as an Outcome of Differential Sensitivity to Environmental Risks in Schizophrenia
- (2010) Petra Habets et al. BIOLOGICAL PSYCHIATRY
- Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
- (2010) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- REVIEW: Genome-Wide Findings in Schizophrenia and the Role of Gene-Environment Interplay
- (2010) Ruud Van Winkel et al. CNS Neuroscience & Therapeutics
- Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists
- (2010) R. Pertwee CURRENT MEDICINAL CHEMISTRY
- Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study
- (2010) Emma Barkus et al. JOURNAL OF PSYCHOPHARMACOLOGY
- TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus
- (2010) Andrés E Chávez et al. NATURE NEUROSCIENCE
- Postsynaptic TRPV1 triggers cell type–specific long-term depression in the nucleus accumbens
- (2010) Brad A Grueter et al. NATURE NEUROSCIENCE
- Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge
- (2010) Paul R.A. Stokes et al. NEUROIMAGE
- Chronic Adolescent Exposure to Δ-9-Tetrahydrocannabinol in COMT Mutant Mice: Impact on Psychosis-Related and Other Phenotypes
- (2010) Colm MP O'Tuathaigh et al. NEUROPSYCHOPHARMACOLOGY
- Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia
- (2010) Matthijs G. Bossong et al. PROGRESS IN NEUROBIOLOGY
- Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: Clinical-onset implications
- (2010) José María Pelayo-Terán et al. PSYCHIATRY RESEARCH
- Chronic cannabis users show altered neurophysiological functioning on Stroop task conflict resolution
- (2010) Robert A. Battisti et al. PSYCHOPHARMACOLOGY
- The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample
- (2010) M. Yucel et al. SCHIZOPHRENIA BULLETIN
- Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines
- (2010) Rebecca Kuepper et al. SCHIZOPHRENIA RESEARCH
- Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
- (2009) Paolo Fusar-Poli et al. ARCHIVES OF GENERAL PSYCHIATRY
- Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood
- (2009) Tiziana Rubino et al. HIPPOCAMPUS
- Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol
- (2009) Paolo Fusar-Poli et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Self-modulation of neocortical pyramidal neurons by endocannabinoids
- (2009) Silvia Marinelli et al. NATURE NEUROSCIENCE
- Can recreational doses of THC produce significant dopamine release in the human striatum?
- (2009) Paul R.A. Stokes et al. NEUROIMAGE
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids
- (2009) N. Realini et al. PHARMACOLOGICAL RESEARCH
- The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
- (2009) P. D. Morrison et al. PSYCHOLOGICAL MEDICINE
- Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence
- (2009) M. Harley et al. PSYCHOLOGICAL MEDICINE
- Neuroimaging in cannabis use: a systematic review of the literature
- (2009) R. Martín-Santos et al. PSYCHOLOGICAL MEDICINE
- From Real-World Events to Psychosis: The Emerging Neuropharmacology of Delusions
- (2009) P. D. Morrison et al. SCHIZOPHRENIA BULLETIN
- Evidence That Onset of Clinical Psychosis Is an Outcome of Progressively More Persistent Subclinical Psychotic Experiences: An 8-Year Cohort Study
- (2009) M. D. G. Dominguez et al. SCHIZOPHRENIA BULLETIN
- Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad
- (2008) M. Konings et al. ACTA PSYCHIATRICA SCANDINAVICA
- COMT Val158Met moderation of cannabis-induced psychosis: a momentary assessment study of ‘switching on’ hallucinations in the flow of daily life
- (2008) C. Henquet et al. ACTA PSYCHIATRICA SCANDINAVICA
- The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction
- (2008) José Antonio López-Moreno et al. ADDICTION BIOLOGY
- Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats
- (2008) Miriam Schneider et al. ADDICTION BIOLOGY
- Regional Brain Abnormalities Associated With Long-term Heavy Cannabis Use
- (2008) Murat Yücel et al. ARCHIVES OF GENERAL PSYCHIATRY
- Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
- (2008) Stefan J. Borgwardt et al. BIOLOGICAL PSYCHIATRY
- Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment
- (2008) Nico Wegener et al. BRAIN RESEARCH
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
- (2008) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala
- (2008) S. C. Azad et al. LEARNING & MEMORY
- Corpus callosum damage in heavy marijuana use: Preliminary evidence from diffusion tensor tractography and tract-based spatial statistics
- (2008) D. Arnone et al. NEUROIMAGE
- Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
- (2008) Matthijs G Bossong et al. NEUROPSYCHOPHARMACOLOGY
- Cannabis use and genetic predisposition for schizophrenia: a case-control study
- (2008) W. Veling et al. PSYCHOLOGICAL MEDICINE
- A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder
- (2008) J. van Os et al. PSYCHOLOGICAL MEDICINE
- Gene-Environment Interactions in Schizophrenia: Review of Epidemiological Findings and Future Directions
- (2008) J. van Os et al. SCHIZOPHRENIA BULLETIN
- Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia
- (2008) M SMITH et al. SCHIZOPHRENIA RESEARCH
- Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD)
- (2008) Chris Hollis et al. SCHIZOPHRENIA RESEARCH
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started